387 related articles for article (PubMed ID: 25645535)
1. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?
Vezzani A
Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.
Terrone G; Salamone A; Vezzani A
Curr Pharm Des; 2017; 23(37):5569-5576. PubMed ID: 28950818
[TBL] [Abstract][Full Text] [Related]
3. Preventing epileptogenesis: A realistic goal?
Terrone G; Pauletti A; Pascente R; Vezzani A
Pharmacol Res; 2016 Aug; 110():96-100. PubMed ID: 27173399
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs.
Sanz P; Rubio T; Garcia-Gimeno MA
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673747
[TBL] [Abstract][Full Text] [Related]
5. The role of glial membrane ion channels in seizures and epileptogenesis.
D'Ambrosio R
Pharmacol Ther; 2004 Aug; 103(2):95-108. PubMed ID: 15369678
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.
Dey A; Kang X; Qiu J; Du Y; Jiang J
Trends Pharmacol Sci; 2016 Jun; 37(6):463-484. PubMed ID: 27062228
[TBL] [Abstract][Full Text] [Related]
7. New pharmacotherapy for epilepsy.
Pitkanen A
IDrugs; 2004 May; 7(5):471-7. PubMed ID: 15154109
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and reactive oxygen species as disease modifiers in epilepsy.
Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A
Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074
[TBL] [Abstract][Full Text] [Related]
9. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.
Löscher W
Neuropharmacology; 2020 May; 167():107605. PubMed ID: 30980836
[TBL] [Abstract][Full Text] [Related]
10. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis.
Frigerio F; Pasqualini G; Craparotta I; Marchini S; van Vliet EA; Foerch P; Vandenplas C; Leclercq K; Aronica E; Porcu L; Pistorius K; Colas RA; Hansen TV; Perretti M; Kaminski RM; Dalli J; Vezzani A
Brain; 2018 Nov; 141(11):3130-3143. PubMed ID: 30307467
[TBL] [Abstract][Full Text] [Related]
11. Epilepsy and brain inflammation.
Vezzani A; Aronica E; Mazarati A; Pittman QJ
Exp Neurol; 2013 Jun; 244():11-21. PubMed ID: 21985866
[TBL] [Abstract][Full Text] [Related]
12. Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.
Pauletti A; Terrone G; Shekh-Ahmad T; Salamone A; Ravizza T; Rizzi M; Pastore A; Pascente R; Liang LP; Villa BR; Balosso S; Abramov AY; van Vliet EA; Del Giudice E; Aronica E; Antoine DJ; Patel M; Walker MC; Vezzani A
Brain; 2017 Jul; 140(7):1885-1899. PubMed ID: 28575153
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies and anti-inflammatory mechanisms of treatments.
French JA; Koepp M; Naegelin Y; Vigevano F; Auvin S; Rho JM; Rosenberg E; Devinsky O; Olofsson PS; Dichter MA
Epilepsia; 2017 Jul; 58 Suppl 3(Suppl 3):69-82. PubMed ID: 28675558
[TBL] [Abstract][Full Text] [Related]
14. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy.
Vezzani A; Balosso S; Maroso M; Zardoni D; Noé F; Ravizza T
Curr Opin Investig Drugs; 2010 Jan; 11(1):43-50. PubMed ID: 20047158
[TBL] [Abstract][Full Text] [Related]
15. The role of neuroinflammation in canine epilepsy.
von Rüden EL; Potschka H; Tipold A; Stein VM
Vet J; 2023; 298-299():106014. PubMed ID: 37393038
[TBL] [Abstract][Full Text] [Related]
16. mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment.
Ravizza T; Scheper M; Di Sapia R; Gorter J; Aronica E; Vezzani A
Nat Rev Neurosci; 2024 May; 25(5):334-350. PubMed ID: 38531962
[TBL] [Abstract][Full Text] [Related]
17. How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
Yu N; Lin XJ; Di Q
Curr Neuropharmacol; 2020; 18(7):624-635. PubMed ID: 31989901
[TBL] [Abstract][Full Text] [Related]
18. Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation.
D'Ambrosio R; Eastman CL; Fattore C; Perucca E
Expert Rev Neurother; 2013 Jun; 13(6):615-25. PubMed ID: 23738999
[TBL] [Abstract][Full Text] [Related]
19. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.
Löscher W; Brandt C
Pharmacol Rev; 2010 Dec; 62(4):668-700. PubMed ID: 21079040
[TBL] [Abstract][Full Text] [Related]
20. Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.
Pauletti A; Terrone G; Shekh-Ahmad T; Salamone A; Ravizza T; Rizzi M; Pastore A; Pascente R; Liang LP; Villa BR; Balosso S; Abramov AY; van Vliet EA; Del Giudice E; Aronica E; Patel M; Walker MC; Vezzani A
Brain; 2019 Jul; 142(7):e39. PubMed ID: 31145451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
